Advanced company searchLink opens in new window

MYOVANT HOLDINGS LIMITED

Company number 10317663

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
12 Aug 2024 CS01 Confirmation statement made on 8 August 2024 with updates
30 Dec 2023 AA Full accounts made up to 31 March 2023
10 Nov 2023 SH01 Statement of capital following an allotment of shares on 10 November 2023
  • USD 25,006
06 Oct 2023 TM01 Termination of appointment of Mark Craig as a director on 6 October 2023
06 Oct 2023 AP01 Appointment of Ms Emma Carys Price as a director on 6 October 2023
27 Sep 2023 RP04CS01 Second filing of Confirmation Statement dated 8 August 2023
20 Sep 2023 PSC02 Notification of Sumitomo Pharma Co., Ltd. as a person with significant control on 10 March 2023
20 Sep 2023 PSC07 Cessation of Myovant Sciences Ltd. as a person with significant control on 10 March 2023
08 Aug 2023 CS01 Confirmation statement made on 8 August 2023 with updates
  • ANNOTATION Clarification a second filed CS01 (capital and shareholder information) was registered on 27/09/2023
16 May 2023 SH19 Statement of capital on 16 May 2023
  • USD 25,005
16 May 2023 SH20 Statement by Directors
16 May 2023 CAP-SS Solvency Statement dated 15/05/23
16 May 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Cancel share prem a/c 15/05/2023
16 Mar 2023 SH01 Statement of capital following an allotment of shares on 14 March 2023
  • USD 25,005
16 Dec 2022 AA Full accounts made up to 31 March 2022
12 Oct 2022 AD01 Registered office address changed from Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022
17 Aug 2022 CS01 Confirmation statement made on 8 August 2022 with updates
07 Mar 2022 SH01 Statement of capital following an allotment of shares on 3 March 2022
  • USD 25,004
20 Dec 2021 AA Full accounts made up to 31 March 2021
09 Aug 2021 CS01 Confirmation statement made on 8 August 2021 with updates
29 Mar 2021 SH01 Statement of capital following an allotment of shares on 24 March 2021
  • USD 25,003
19 Mar 2021 AA Full accounts made up to 31 March 2020
10 Aug 2020 CS01 Confirmation statement made on 8 August 2020 with updates
31 Mar 2020 SH01 Statement of capital following an allotment of shares on 30 March 2020
  • USD 25,002
22 Jan 2020 MR04 Satisfaction of charge 103176630003 in full